Relevant models for brain medicine


Human brain is the one organ that defines our existence and is irreplaceable.

Brain disorders like depression or Alzheimer’s disease affect more than a billion patients.

However, due to the brain's complexity and our little understanding, only 6% of new medicine candidates succeed in clinical trials.

The Need

There are 970 million people with mental illnesses like depression or schizophrenia. One third of patients with mental illness will never find a medicine that alleviates their symptoms, while severe side effects of approved medicines make 20% of these patients stop using it. There is no cure for neurodegenerative disorders like Alzheimer’s or Parkinson’s, which affect over 50 million people.

Our Solution

We develop a platform for candidate drug testing using

human cell-based brain organoids - minibrains.

Minibrains are made of human cells and simulate certain functions of the real human brain.


Our vision is to make medicine discovery more effective and minimize use of animals.

We help pharmaceutical companies make qualified business decisions and increase the chances for a successful clinical trial.

Supported by